Xinyue Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xinyue Liu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chi Liu
College of Chinese Medicinal Material, Jilin Agricultural University, 2888 Xincheng Street, Changchun 130118, China
2 shared publications - Enbo Cai
College of Chinese Medicinal Material, Jilin Agricultural University, 2888 Xincheng Street, Changchun, Jilin Province 130118, China
2 shared publications - Fengyan Su
College of Chinese Medicinal Material, Jilin Agricultural University, 2888 Xincheng Street, Changchun 130118, China
2 shared publications - Qing Ma
College of Chinese Medicinal Material, Jilin Agricultural University, 2888 Xincheng Street, Changchun 130118, China
2 shared publications - Dan Wang
College of Chinese Medicinal Material, Jilin Agricultural University, Changchun 130118, PR China
1 shared publication - Zhiwei Liu
College of Chinese Medicinal Material, Jilin Agricultural University, Changchun 130118, PR China
1 shared publication
Latest Publications
- Open Access
Design, Synthesis, and Antitumor Activity of Isoliquiritigenin Amino Acid Ester Derivatives
Isoliquiritigenin (ISL) is a chalcone that has shown great potential in the treatment of cancer. However, its relatively weak activity and low water solubility limit its clinical application. In this study, we designed and synthesized 21 amino acid ester derivatives of ISL and characterized the compounds using 1H NMR and 13C NMR. Among them, compound 9 (IC50 = 14.36 μM) had a better inhibitory effect on human cervical cancer (Hela) than ISL (IC50 = 126.5 μM), and it was superior to the positive drug 5-FU (IC50 = 33.59 μM). The mechanism of the action experiment showed that compound 9 could induce Hela cell apoptosis and autophagy through the PI3K/Akt/mTOR pathway.
Open AccessDesign, Synthesis, and Antitumor Activity of Isoliquiritigenin Amino Acid Ester Derivatives
Isoliquiritigenin (ISL) is a chalcone that has shown great potential in the treatment of cancer. However, its relatively weak activity and low water solubility limit its clinical application. In this study, we designed and synthesized 21 amino acid ester derivatives of ISL and characterized the compounds using 1H NMR and 13C NMR. Among them, compound 9 (IC50 = 14.36 μM) had a better inhibitory effect on human cervical cancer (Hela) than ISL (IC50 = 126.5 μM), and it was superior to the positive drug 5-FU (IC50 = 33.59 μM). The mechanism of the action experiment showed that compound 9 could induce Hela cell apoptosis and autophagy through the PI3K/Akt/mTOR pathway.